Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1998
12/23/1998CA2294569A1 Secreted proteins and polynucleotides encoding them
12/23/1998CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998CA2294047A1 Crystalline roxifiban
12/23/1998CA2291442A1 Novel guanidine mimics as factor xa inhibitors
12/23/1998CA2290982A1 Inhibitors of factor xa with a neutral p1 specificity group
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852051 Dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals
12/22/1998US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same
12/22/1998US5852004 Drug and pharmaceutical composition for the treatment of lesions of the digestive tract
12/22/1998US5851990 bFGF mutein and its production
12/22/1998US5851984 Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
12/22/1998US5851800 Process for producing a protein
12/22/1998CA2126699C An iron-containing composition for the prevention of anaemia and a method for producing the composition
12/17/1998WO1998056916A1 Aprotinin variants with improved properties and bikunins of aprotinin variants
12/17/1998WO1998056814A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
12/17/1998WO1998056759A2 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
12/17/1998WO1998056394A1 Compositions useful as fibrin sealants
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998WO1998056370A2 Therapeutic nanospheres
12/17/1998WO1998056365A1 COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT
12/17/1998WO1998056247A1 Platelet suspensions and methods for resuspending platelets
12/17/1998WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
12/17/1998WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998DE19826781A1 Pentaerythritol derivatives
12/17/1998DE19725014A1 Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten Aprotinin variants with improved properties and Bikunine of aprotinin
12/17/1998CA2303268A1 Therapeutic nanospheres
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2293499A1 Compositions useful as fibrin sealants
12/17/1998CA2293407A1 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
12/17/1998CA2290389A1 Platelet suspensions and methods for resuspending platelets
12/16/1998EP0884326A2 Antithrombitic compound
12/16/1998EP0883625A1 Novel platelet activation protein
12/16/1998EP0883405A1 Amidino protease inhibitors
12/16/1998EP0687253B1 4-aminopyridines, process for preparing the same and medicaments containing the same
12/16/1998CN1202175A Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix
12/16/1998CN1202168A Quinolein-2(1H)-one derivatives as serotonin antagonists
12/16/1998CN1202113A Pharmaceutical combination preparations containing erythropoietin and iron preparation
12/16/1998CN1041203C Preparation of pyrazolopyridine compound
12/15/1998US5849919 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor anonist activity
12/15/1998US5849759 Naphthyl-substituted benzimidazole derivatives as anti-coagulants
12/15/1998US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998US5849693 Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIb/IIIa
12/15/1998US5849690 Anti-aggregatory peptides
12/15/1998US5849688 Transgenic,cross-linked hemoglobin
12/15/1998US5849507 Methods to diagnose thrombosis by measuring activation peptide
12/15/1998US5849287 Gene therapy using stromal cells
12/15/1998US5849283 Human interleukin-6 receptor antagonists
12/15/1998CA1340270C Thrombolytic composition and a process for production thereof
12/15/1998CA1340197C Hirudin derivatives with delayed action
12/15/1998CA1340187C Peptides that inhibit von willebrand factor binding
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055619A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998WO1998055514A1 Oligosaccharide mixtures having antithrombotic activity
12/10/1998WO1998055506A2 Thrombin-inhibiting peptide
12/10/1998WO1998055504A1 HsPLA2 GR II PEPTIDES EXHIBITING AN ANTICOAGULANT EFFECT
12/10/1998WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998WO1998055468A1 Oxazole compounds useful as pge2 agonists and antagonists
12/10/1998WO1998055142A1 Methods for treating thrombotic disorders
12/10/1998WO1998055105A1 Fibrinogen-coated microspheres
12/10/1998WO1998055074A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1998DE19724791A1 Thrombin hemmende Peptide Thrombin inhibitory peptides
12/10/1998CA2294494A1 Fibrinogen-coated microspheres
12/10/1998CA2293693A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998CA2293587A1 Oligosaccharide mixtures having antithrombotic activity
12/10/1998CA2293429A1 Methods for treating thrombotic disorders
12/10/1998CA2292668A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/09/1998EP0882453A2 Methods for treating thrombotic disorders
12/09/1998EP0881901A1 New associations of active principles containing clopidogrel and an antithrombotic agent
12/09/1998EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998EP0332667B2 Vector for integration site independent gene expression in mammalian host cells
12/09/1998CN1201447A Butyrate prodrugs of lactic acid
12/09/1998CN1201397A Improved prescription for steroid compound administration
12/09/1998CN1201391A Use of flupirtin for prevention and treatment of disease which are associated with damage to haemopoietic cell system
12/09/1998CN1041087C Arylacetamides, preparation method and use thereof
12/08/1998US5847159 1- ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
12/08/1998US5847093 Human apoptosis regulator
12/08/1998US5847086 Therapeutic fragments of von Willebrand factor
12/08/1998US5847085 Modified protein C and methods of use thereof
12/08/1998US5847078 Polypeptide capable of differentiating and maturing malignant cells into normal cells or capable of accelerating the formulation of erythroblasts
12/08/1998US5847000 Fatty acid derivatives
12/08/1998US5846972 Bicyclic pyrimidine derivatives and their use as anti-coagulants
12/08/1998US5846970 Bicyclic pyrimidine derivatives and their use as anti-coagulants
12/08/1998US5846967 Natriuretic and anti-hypertensive compounds
12/08/1998US5846963 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/08/1998US5846958 Methods of using aminothiols to promote hematopoietic progenitor cell growth
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998US5846572 Body fluid replacement solution
12/08/1998US5846528 Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
12/08/1998US5846458 Inhibition adsorption of proteins on the liposome surface
12/05/1998CA2239593A1 Method for synthesis of anhydrothrombin
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054199A1 Tissue plasminogen activator-like protease
12/03/1998WO1998054164A1 Sulfonamide derivatives, their production and use
12/03/1998WO1998054138A1 Novel orally active iron (iii) chelators
12/03/1998WO1998053848A1 PHARMACEUTICAL PREPARATION COMPRISING vWF PROPEPTIDE
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053834A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
12/03/1998WO1998053829A1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 671